These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2965835)

  • 1. Evidence that IFN-gamma is responsible for natural suppressor activity in GVHD spleen and normal bone marrow.
    Holda JH; Maier T; Claman HN
    Transplantation; 1988 Apr; 45(4):772-7. PubMed ID: 2965835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
    Maier T; Holda JH
    J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural suppressor activity in graft-vs-host spleen and normal bone marrow is augmented by IL 2 and interferon-gamma.
    Holda JH; Maier T; Claman HN
    J Immunol; 1986 Dec; 137(11):3538-43. PubMed ID: 2946763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine natural suppressor cells in the newborn, in bone marrow, and after cyclophosphamide. Genetic variations and dependence on IFN-gamma.
    Maier T; Holda JH; Claman HN
    J Immunol; 1989 Jul; 143(2):491-8. PubMed ID: 2525587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor function of liver mononuclear cells isolated during murine chronic graft-vs-host disease. II. Role of prostaglandins and interferon-gamma.
    Howell CD; Yoder TY; Vierling JM
    Cell Immunol; 1992 Mar; 140(1):54-66. PubMed ID: 1531454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism between T and non-T cells in the in vivo induction and in vitro expression of graft-vs.-host disease-induced natural suppressor cells.
    Maier T; Holda JH; Claman HN
    J Exp Med; 1985 Sep; 162(3):979-92. PubMed ID: 3161977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of bone marrow-derived natural suppressor activity by glucocorticoids and its reversal by IFN-gamma or IL-2.
    Rodríguez R; Angulo I; Viñuela JE; Medina M; Gil J; Subiza JL
    Transplantation; 1994 Aug; 58(4):511-7. PubMed ID: 8073521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency.
    Wall DA; Sheehan KC
    Transplantation; 1994 Jan; 57(2):273-9. PubMed ID: 8310520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-3, IL-4, and IL-6 enhance IFN-gamma-dependent bone marrow natural suppressor activity.
    Holda JH; Maier T; Claman HN
    Cell Immunol; 1990 Feb; 125(2):459-68. PubMed ID: 2137035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced interferon-alpha/beta (IFN-alpha/beta) and defective IFN-gamma production in chronic graft versus host disease: a potential mechanism for immunosuppression.
    Cleveland MG; Lane RG; Klimpel GR
    Cell Immunol; 1987 Nov; 110(1):120-30. PubMed ID: 3119228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine regulation of bone marrow natural suppressor cell activity in the suppression of lymphocyte function.
    Moore SC; Theus SA; Barnett JB; Soderberg LS
    Cell Immunol; 1992 May; 141(2):398-408. PubMed ID: 1533570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.
    Young MR; Young ME; Wepsic HT
    Exp Hematol; 1988 May; 16(4):295-301. PubMed ID: 2966070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression and lymphoid hypoplasia associated with chronic graft versus host disease is dependent upon IFN-gamma production.
    Klimpel GR; Annable CR; Cleveland MG; Jerrells TR; Patterson JC
    J Immunol; 1990 Jan; 144(1):84-93. PubMed ID: 2104894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
    J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of nitric oxide in bone marrow-derived natural suppressor activity. Its dependence on IFN-gamma.
    Angulo I; Rodríguez R; García B; Medina M; Navarro J; Subiza JL
    J Immunol; 1995 Jul; 155(1):15-26. PubMed ID: 7541413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease.
    Palathumpat V; Dejbakhsh-Jones S; Holm B; Strober S
    J Immunol; 1992 Aug; 149(3):808-17. PubMed ID: 1386094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of murine bone marrow-derived natural suppressor cells. Potential relationships between NS and NK/LAK activities.
    Saffran DC; Singhal SK
    Cell Immunol; 1990 Jun; 128(1):301-13. PubMed ID: 2140533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.
    Levy RB; Jones M; Hamilton BL; Paupe J; Horowitz T; Riley R
    J Immunol; 1995 Jan; 154(1):106-15. PubMed ID: 7995931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.